GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (STU:CP60) » Definitions » Operating Cash Flow per Share

The Cooper (STU:CP60) Operating Cash Flow per Share : €2.55 (TTM As of Apr. 2024)


View and export this data going back to 1983. Start your Free Trial

What is The Cooper Operating Cash Flow per Share?

The Cooper's operating cash flow per share for the three months ended in Apr. 2024 was €0.52. The Cooper's operating cash flow per share for the trailing twelve months (TTM) ended in Apr. 2024 was €2.55.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of The Cooper was -20.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -0.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for The Cooper's Operating Cash Flow per Share or its related term are showing as below:

STU:CP60' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -20.4   Med: 12.75   Max: 87
Current: 7.5

During the past 13 years, The Cooper's highest 3-Year average Operating Cash Flow per Share Growth Rate was 87.00% per year. The lowest was -20.40% per year. And the median was 12.75% per year.

STU:CP60's 3-Year OCF Growth Rate is ranked better than
57.35% of 687 companies
in the Medical Devices & Instruments industry
Industry Median: 2.5 vs STU:CP60: 7.50

The Cooper Operating Cash Flow per Share Historical Data

The historical data trend for The Cooper's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Operating Cash Flow per Share Chart

The Cooper Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.22 2.09 3.20 3.54 2.89

The Cooper Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.65 0.83 0.56 0.52

Competitive Comparison of The Cooper's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, The Cooper's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Cooper's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where The Cooper's Price-to-Operating-Cash-Flow falls into.



The Cooper Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

The Cooper's Operating Cash Flow per Share for the fiscal year that ended in Oct. 2023 is calculated as

Operating Cash Flow per Share (A: Oct. 2023 )=Cash Flow from Operations (A: Oct. 2023 )/Shares Outstanding (Diluted Average) (A: Oct. 2023 )
=575.302/199.200
=2.89

The Cooper's Operating Cash Flow per Share for the quarter that ended in Oct. 2023 is calculated as

Operating Cash Flow per Share (Q: Apr. 2024 )=Cash Flow from Operations (Q: Apr. 2024 )/Shares Outstanding (Diluted Average) (Q: Apr. 2024 )
=103.452/200.500
=0.52

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Cooper Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of The Cooper's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


The Cooper (STU:CP60) Business Description

Traded in Other Exchanges
Address
6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (STU:CP60) Headlines

No Headlines